Adherence of gastroenterologists to European Crohn's and Colitis Organisation Consensus on Crohn's disease: A real-life survey in Spain

被引:14
|
作者
Hinojosa, J. [1 ]
Gisbert, J. P. [3 ,4 ]
Gomollon, F. [2 ,4 ]
San Roman, A. Lopez [5 ]
机构
[1] Hosp Manises, Dept Gastroenterol, Valencia, Spain
[2] Univ Zaragoza, Hosp Clin, Dept Gastroenterol, E-50009 Zaragoza, Spain
[3] Hosp Univ La Princesa, Dept Gastroenterol, Inst Invest Sanitaria Princesa IP, Madrid, Spain
[4] CIBEREHD, Madrid, Spain
[5] Hosp Ramon & Cajal, IBDnet, Dept Gastroenterol, E-28034 Madrid, Spain
关键词
Crohn's disease; ECCO clinical guidelines; Inflammatory bowel disease; Questionnaire; INFLAMMATORY-BOWEL-DISEASE; PRACTICE GUIDELINES; INFLIXIMAB; DIAGNOSIS; COSTS; IBD;
D O I
10.1016/j.crohns.2011.12.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: There is no information as to the extent by which Spanish gastroenterologists adhere to Crohn's disease (CD) management guidelines. The objective of this study was to evaluate the degree of adherence of Spanish gastroenterologists to the European Crohn's and Colitis Organisation (ECCO) guidelines and to determine whether differences in adherence exist between gastroenterologists specialized in inflammatory bowel diseases (GSIBDs) and general gastroenterologists (GGs). Methods: This was a prospective, nation-wide, questionnaire-based survey covering aspects related to diagnosis, treatment, follow-up, and safety considered by the physicians in their daily management of CD, as well as demographic traits seen in clinical practice. Results: The overall degree of adherence to guidelines by both GSIBDs and GGs was high. However, the use of imaging techniques in diagnosis, follow-up, and in relapsed patients differed between the two groups. In the diagnosis of perianal disease, GSIBDs used magnetic resonance and surgical exploration under anesthesia more frequently than GGs. In terms of therapeutic choices, the adherence to guidelines was good in both groups. However, GSIBDs showed significantly higher adherence in some areas: thiopurines were used less in refractory cases and methotrexate was used more commonly in corticoid-dependent, azathioprine-intolerant patients, and in patients under biological treatment. Request for infection studies and vaccinations at diagnosis or prior to treatment was more common among GSIBDs. Conclusions: Guideline adherence among Spanish gastroenterologists is high. However, there are significant differences between IBD-specialized (more adherent in general) and non-specialized gastroenterologists. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:763 / 770
页数:8
相关论文
共 50 条
  • [21] European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease
    Doherty, Glen
    Katsanos, Konstantinos H.
    Burisch, Johan
    Allez, Matthieu
    Papamichael, Konstantinos
    Stallmach, Andreas
    Mao, Ren
    Berset, Ingrid Prytz
    Gisbert, Javier P.
    Sebastian, Shaji
    Kierkus, Jaroslaw
    Lopetuso, Loris
    Szymanska, Edyta
    Louis, Edouard
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (01) : 17 - 31
  • [22] Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries
    Kante, Bhaskar
    Vuyyuru, Sudheer Kumar
    Kedia, Saurabh
    Sahu, Pabitra
    Kumar, Peeyush
    Ranjan, Mukesh Kumar
    Virmani, Shubi
    Sharma, Raju
    Madhusudhan, Kumble Seetharama
    Panwar, Rajesh
    Das, Prasenjit
    Makharia, Govind
    Ahuja, Vineet
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2022, 41 (04) : 343 - 351
  • [23] Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE)
    Eberl, Anja
    Hallinen, Taru
    af Bjorkesten, Clas-Goran
    Heikkinen, Markku
    Hirsi, Eija
    Kellokumpu, Mikko
    Koskinen, Inka
    Moilanen, Veikko
    Nielsen, Christian
    Nuutinen, Heikki
    Suhonen, Ulla-Maija
    Utriainen, Karri
    Vihriala, Ilkka
    Soini, Erkki
    Wennerstrom, Christina
    Nissinen, Riikka
    Borsi, Andras
    Koivunen, Minni
    Tillonen, Jyrki
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 718 - 725
  • [24] Living with inflammatory bowel disease: A Crohn's and Colitis Canada survey
    Becker, Helen M.
    Grigat, Daniel
    Ghosh, Subrata
    Kaplan, Gilaad G.
    Dieleman, Levinus
    Wine, Eytan
    Fedorak, Richard N.
    Fernandes, Aida
    Panaccione, Remo
    Barkema, Herman W.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (02) : 77 - 84
  • [25] Psoriasis associated with ulcerative colitis and Crohn's disease
    Cohen, A. D.
    Dreiher, J.
    Birkenfeld, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (05) : 561 - 565
  • [26] Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper
    Fiorino, Gionata
    Lytras, Theodore
    Younge, Lisa
    Fidalgo, Catarina
    Coenen, Sofie
    Chaparro, Maria
    Allocca, Mariangela
    Arnott, Ian
    Bossuyt, Peter
    Burisch, Johan
    Campmans-Kuijpers, Marjo
    de Ridder, Lissy
    Dignass, Axel
    Drohan, Ciara
    Feakins, Roger
    Gilardi, Daniela
    Grosek, Jan
    Gross, Evelyn
    Hart, Ailsa
    Jaghult, Susanna
    Katsanos, Konstantinos
    Lonnfors, Sanna
    Panis, Yves
    Perovic, Marko
    Pierik, Marieke
    Rimola, Jordi
    Tulchinsky, Hagit
    Gisbert, Javier P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (08) : 1037 - 1048
  • [27] Patient experiences with and adherence to Crohn's disease exclusion diet in Dutch Crohn's disease patients: a cohort study
    Wijers, Fleur T. R.
    van Zundert, Suzanne M. C.
    Verburgt, Charlotte M.
    van der Kruk, Nikki
    Van Limbergen, Johan E.
    Wierdsma, Nicolette J.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2025, 18
  • [28] The role of filgotinib in ulcerative colitis and Crohn's disease
    Fanizza, Jacopo
    D'Amico, Ferdinando
    Lauri, Gaetano
    Martinez-Dominguez, Samuel J.
    Allocca, Mariangela
    Furfaro, Federica
    Zilli, Alessandra
    Fiorino, Gionata
    Parigi, Tommaso Lorenzo
    Radice, Simona
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    IMMUNOTHERAPY, 2024, 16 (02) : 59 - 74
  • [29] Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn's disease or ulcerative colitis
    Gheorghe, Cristian
    Svoboda, Pavel
    Mateescu, Bogdan
    JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 129 - 134
  • [30] Quality of life and uncertainty in Crohn's disease
    Niv, Galia
    Bar Josef, Simona
    Ben Bassat, Ofer
    Avni, Irit
    Lictenstein, Lev
    Niv, Yaron
    Barnoy, Sivia
    QUALITY OF LIFE RESEARCH, 2017, 26 (06) : 1609 - 1616